The head of Germany’s Boehringer Ingelheim has said that he “regrets” Brexit, but reassured patients in the country that the company still regards it as an important market for new drug lau
Pharma has urged politicians to reject a no-deal Brexit in today’s crunch vote, reiterating warnings that this would disrupt supplies of critical medicines.